KLP Kapitalforvaltning’s Amphastar Pharmaceuticals AMPH Stock Holding History

KLP Kapitalforvaltning’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Hold	7,900	–	–	﹤0.01%	1976
2026 Q1	$155K	Hold	7,900	–	–	﹤0.01%	1914
2025 Q4	$212K	Buy	7,900 +500	+7%	+$12.9K	﹤0.01%	1817
2025 Q3	$197K	Hold	7,400	–	–	﹤0.01%	1833
2025 Q2	$170K	Hold	7,400	–	–	﹤0.01%	1846
2025 Q1	$215K	Hold	7,400	–	–	﹤0.01%	1722
2024 Q4	$275K	Buy	+7,400	New	+$338K	﹤0.01%	1691

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

KLP Kapitalforvaltning's AMPH Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 7,900 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

KLP Kapitalforvaltning first reported a position in AMPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $275K in Q4 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

KLP Kapitalforvaltning held 7,900 shares of Amphastar Pharmaceuticals worth $159K as of Q2 2026.
KLP Kapitalforvaltning left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1976 holding.
KLP Kapitalforvaltning first reported a position in Amphastar Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Amphastar Pharmaceuticals position peaked at $275K in Q4 2024.
212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.